Ole K. Møller-Helgestad 1 In collaboration with CB Poulsen, MD 2 EH Christiansen, MD, PhD 2 JF Lassen, MD, PhD 2 HB Ravn, MD, PhD, DMSc 1 1: Dept. of.

Slides:

Advertisements

Similar presentations

CORONARY CARE UNIT (CCU)

Advertisements

© 2010, American Heart Association. All rights reserved. A Validated Risk Score for In-hospital Mortality in Patients with Heart Failure from the American.

Protecting the heart and the kidney: Implications from the SHARP trial Dr. Christina Reith University of Oxford United Kingdom.

Cardiology Morning Report: Revascularization in Stable Ischemic Heart Disease Bobby Mathew, MD LSU Internal Medicine, HO-II.

Relationship of Time to Treatment and Door-to-Balloon Time to Mortality in Patients with Acute Myocardial Infarction Treated with Primary Angioplasty Christopher.

Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials Elgendy IY et al. Am J Hypertens. 2014; doi:10,1093/ajh/hpu209.

Clinical Trial Results. org Rescue Angioplasty or Repeat Fibrinolysis After Failed Fibrinolytic Therapy for ST-Segment Myocardial Infarction: A Meta-Analysis.

THERAPEUTIC HYPOTHERMIA Heike Geduld August 2007.

ST-Elevation Myocardial Infarction & Cardiogenic Shock - What Should We Do? Advanced Angioplasty 2008 Dan Blackman Leeds General Infirmary.

Unstable Angina /Non-ST Elevation Myocardial Infarction Critical Pathway Toolkit Adapted from Dr Chris Cannon STRIVE Scientific Committee – 2008 Based.

Vascular Dysfunction: Sequelae of Acute Hypertension.

New guidelines for CABG

Revascularizaton of Ischemic DCM Percutaneous Revascularization and Hemodynamic Support Matthew R. Wolff, M.D. University of Wisconsin Disclosures: Cordis.

How and when should we monitor CO and SV in shock? When would I want to measure CO or SV in shock ? Alexandre Mebazaa, MD, PhD University Paris 7 Anesthesiology.

ITU Journal Club: Dr. Clinton Jones. ST4 Anaesthetics.

Treatment and Risk in Heart Failure: Gaps in Evidence or Quality? Pamela N. Peterson, MD MSPH; John S. Rumsfeld, MD PhD; Li Liang PhD; Adrian F. Hernandez,

Top Papers in Critical Care 2013 Janna Landsperger RN, MSN, ACNP-BC.

Mechanical Circulatory Support Cardiogenic Shock Post AMI

Percutaneous Mechanical Circulatory Support Devices

Surgically-BasedDevice VSD Closure Olaf Wendler Department of Cardiothoracic Surgery King‘s College Hospital.

AB 1/03 Non-Coronary Intervention Circulatory Support Advanced Angioplasty 2003 Andreas Baumbach Bristol Royal Infirmary.

Which Beta-Blocker is Best for Patients with Heart Failure? Summary and Comment by Joel M. Gore, MD Published in Journal Watch Cardiology December 17,

Copenhagen University Hospital Rigshospitalet, Denmark

Ihab Alomari, MD, FACC Assistant professor – Interventional Cardiology University of California, Irvine Division of Cardiology Cath Lab Essentials : LV.

Aortic Symposium 2012 Short Term Outcomes in Endovascular and Open Repair of Thoracic Aortic Aneurysms Are Controversial Through NSQIP Alexander I. Kraev,

Types of Hemodynamic Support in the Cath Lab.

Increased Patient Device Concerns But Not General Anxiety in Patients with a Secondary Indication for the ICD Susanne S. Pedersen, Professor of Cardiac.

Conflict of Interest Baxter Research Grant Medtronic Research Grant

Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.

Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Assessment of the area at risk after acute myocardial infarction.

An AKI project for critically ill cancer patients

Detroit Cardiogenic Shock Initiative

Contemporary Approaches to Acute Mechanical Circulatory Support

Why are most clinical research findings not spectacular?

Surgical ICU, Heart Institute University of São Paulo

Christian S. Meyhoff, MD, PhD

Improving Outcomes in Cardiogenic Shock

Abiomed ELAB Meeting March 3, 2017

Copenhagen University Hospital Rigshospitalet, Denmark

Lipid hydroperoxide levels (μM) in hepatic tissue lyaste after 1 and 5 h of reperfusion after 60 min of ischemia. Lipid hydroperoxide levels (μM) in hepatic.

Assist Devices for the Treatment of Cardiogenic Shock

TAVI Passed the Exam and is Ready for Clinical Use in Inoperable Patients Disclosures Research Funding and Speaking Honoraria: Edwards Lifesciences.

Role of ECMO in Acute Cardiogenic Shock

SSAI Malmö MD, PhD, FCICM, EDIC Markus Skrifvars

circulatory support in cardiogenic shock

Mechanical circulatory support

American College of Cardiology Foundation/American Heart Association 2009 heart failure staging guidelines. CHF, congestive heart failure; CM, cardiomyopathy;

Is There a Role for Aspiration in STEMI?

Extracorporeal Life Support (ECLS)

The Use of Impella for CGS Patients Does It Save Lives?

Cardiogenic Shock.

The Clinical Enigma of Cardiogenic Shock

بهداشت فردي.

Percutaneous Mechanical Circulatory Support Devices

STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES

Support with intra-aortic balloon pump vs. Impella2

Empirical antibiotic treatment algorithm for hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP). Empirical antibiotic treatment algorithm.

Physiology Myocardial Oxygen Supply and Demanda,b.

Computed electroencephalographic topographic brain mapping

Editorial Heart Failure Clinics

Brian R. Weil et al. BTS 2017;2: Brief Myocardial Ischemia Produces Transient LV Dysfunction Consistent With Stunned Myocardium A 10-min total left.

Pericarditis Inflammation of the pericardium Many causes

IMPRESS Trial design: Patients undergoing primary PCI for STEMI and cardiogenic shock were randomized in a 1:1 to either Impella CP or IABP. They were.

Evaluating the Science of Cardiogenic Shock

UK paediatric cardiac surgery mortality rate by year for all cases and total number of procedures performed between 2000 and 2009/2010. UK paediatric cardiac.

Orly Vardeny et al. JCHF 2016;4:

CIRCUS Trial design: Patients with anterior STEMI were randomized to IV cyclosporine 2.5 mg/kg (n = 475) vs. placebo (n = 495) immediately before coronary.

Kaplan-Meier estimates of all-cause mortality at 30 days.

Independent predictors of all-cause mortality at 30 days.

Associations of dialysis session length with mortality and hospitalizations. Associations of dialysis session length with mortality and hospitalizations.

Presentation transcript:

Ole K. Møller-Helgestad 1 In collaboration with CB Poulsen, MD 2 EH Christiansen, MD, PhD 2 JF Lassen, MD, PhD 2 HB Ravn, MD, PhD, DMSc 1 1: Dept. of Anaesthesiology and Intensive Care, Aarhus University Hospital 2: Dept. of Cardiology, Aarhus University Hospital IMPELLA2.5® VS. IABP IN CARDIOGENIC SHOCK SNOWMASS March 11, 2014 DENMARK Norway Sweden U.K. Finland

BACKGROUND Mortality ( %) IMPELLA2.5® VS IABP SNOWMASS March 11, 2014 No improvement for the last 15 years Goldberg R J et al. Circulation. 2009;119: BACKGROUNDCONCLUSIONRESULTSSTUDY DESIGN

TREATMENT Anticoagulation Inotropics Vasopressors Revascularisation ? Guidelines European Society of Cardiology American Heart Association BACKGROUNDCONCLUSIONRESULTSSTUDY DESIGN IMPELLA2.5® VS IABP SNOWMASS March 11, 2014

STUDY DESIGN LV failure IABP Impella IABP Impella No support IABP+ Impella 15 min min LAD Ischemia 45 min 13 Pigs min Reperfusion 30 min. BACKGROUNDCONCLUSIONRESULTSSTUDY DESIGN IMPELLA2.5® VS IABP SNOWMASS March 11, 2014

RESULTS Analysed by one-way ANOVA Renal blood flowCarotid blood flow BACKGROUNDCONCLUSIONRESULTSSTUDY DESIGN IMPELLA2.5® VS IABP SNOWMASS March 11, 2014

0.31 watts RESULTS 0.2W CP = 45% Mortality risk Cardiac Power (CP) = (watt) CO × MAP 451 Analysed by one-way ANOVA BACKGROUNDCONCLUSIONRESULTSSTUDY DESIGN IMPELLA2.5® VS IABP SNOWMASS March 11, 2014

CONCLUSION In this study, the Impella2.5® was superior to the IABP when it comes to: Improving blood flow to the brain and kidneys Improving cardiac function Suggests impoved outcome on Impella2.5 support, but RCTs are needed BACKGROUNDCONCLUSIONRESULTSSTUDY DESIGN IMPELLA2.5® VS IABP SNOWMASS March 11, 2014

THANK YOU FOR LISTENING IMPELLA2.5® VS IABP SNOWMASS March 11, 2014